{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:38:16Z","timestamp":1788871096989,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Ci\u00eancia e Tecnologia do Estado de Pernambuco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.tice.2014.08.001","type":"journal-article","created":{"date-parts":[[2014,8,11]],"date-time":"2014-08-11T15:30:21Z","timestamp":1407771021000},"page":"439-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effect of chronic Sildenafil treatment on the prostate of C57Bl\/6 mice"],"prefix":"10.1016","volume":"46","author":[{"given":"Fabiana Oliveira dos Santos","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria da Concei\u00e7\u00e3o","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Lidianne Alc\u00e2ntara","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edlene Lima","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Karolina Soares","family":"e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3361-2789","authenticated-orcid":false,"given":"Mariana Arag\u00e3o Matos","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2312-085X","authenticated-orcid":false,"given":"Sura Wanessa Santos","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Santos","family":"e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina Alves","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2014.08.001_bib0005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1464-410x.2000.00787.x","article-title":"The prognostic value of inducible nitric oxide synthase in local prostate cancer","volume":"86","author":"Aaltomaa","year":"2000","journal-title":"BJU Int."},{"key":"10.1016\/j.tice.2014.08.001_bib0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/pros.10077","article-title":"Lysophosphatidic acid stimulates proliferation of cultured smooth muscle cells from human BPH tissue: sildenafil and papaverin generate inhibition","volume":"51","author":"Adolfsson","year":"2002","journal-title":"Prostate"},{"key":"10.1016\/j.tice.2014.08.001_bib0015","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/nau.20485","article-title":"LUTS treatment: future treatment options","volume":"26","author":"Andersson","year":"2007","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.tice.2014.08.001_bib0020","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1073\/pnas.91.12.5330","article-title":"Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP","volume":"91","author":"Bang","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tice.2014.08.001_bib0025","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.eururo.2007.06.048","article-title":"Daily administration of phosphodiesterase Type 5 inhibitors for urological and nonurological indications","volume":"52","author":"Bella","year":"2007","journal-title":"Eur. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0030","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nrc951","article-title":"Bloodborne biomolecular markers in prostate cancer development and progression","volume":"2","author":"Bok","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tice.2014.08.001_bib0035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0090-4295(99)80012-0","article-title":"Characterization and localization of nitric oxide synthase in the human prostate","volume":"45","author":"Burnett","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.tice.2014.08.001_bib0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1158\/0008-5472.CAN-06-1478","article-title":"Stromal\u2013epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer","volume":"67","author":"Cano","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.tice.2014.08.001_bib0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/1097-4652(200009)184:3<409::AID-JCP16>3.0.CO;2-K","article-title":"Molecular mechanism of cGMP-mediated smooth muscle relaxation","volume":"184","author":"Carvajal","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tice.2014.08.001_bib0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00357069","article-title":"Prostate epithelial differentiation is dictated by its surrounding stroma","volume":"23","author":"Chung","year":"1996","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.tice.2014.08.001_bib0055","first-page":"1046","article-title":"Prostate-specific antigen (PSA) is an insulinlike growth factor binding protein-3 protease found in seminal plasma","volume":"75","author":"Cohen","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tice.2014.08.001_bib0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0898-6568(03)00134-7","article-title":"Protein kinase G II-mediated proliferative effects in human cultured prostatic stromal cells","volume":"16","author":"Cook","year":"2004","journal-title":"Cell Signal."},{"key":"10.1016\/j.tice.2014.08.001_bib0065","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/sj.onc.1209984","article-title":"Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression","volume":"26","author":"Cronauer","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.tice.2014.08.001_bib0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsbmb.2004.10.017","article-title":"Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development","volume":"92","author":"Cunha","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tice.2014.08.001_bib0080","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2011.11.013","article-title":"The correlation between metabolic syndrome and prostatic diseases","volume":"61","author":"De Nunzio","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s003450100220","article-title":"Insulin-like growth factors and prostate cancer","volume":"19","author":"Djavan","year":"2001","journal-title":"World J. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0095","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/10408369991239213","article-title":"Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action","volume":"36","author":"Francis","year":"1999","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.tice.2014.08.001_bib0100","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/pros.21125","article-title":"Androgens, growth factors, and risk of prostate cancer: the Multiethnic Cohort","volume":"70","author":"Gill","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.tice.2014.08.001_bib0105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1442-2042.1999.00069.x","article-title":"The effect of papaverine on morphologic differentiation, proliferation and invasive potential of human prostatic cancer LNCaP cells","volume":"6","author":"Goto","year":"1999","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0110","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s11884-013-0184-9","article-title":"PDE5-Is for the treatment of concomitant ED and LUTS\/BPH","volume":"8","author":"Gacci","year":"2013","journal-title":"Curr. Bladder Dysfunct. Rep."},{"key":"10.1016\/j.tice.2014.08.001_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2125.1993.tb05662.x","article-title":"Isoenzyme selective phosphodiesterase inhibitors: potential clinical uses","volume":"35","author":"Hall","year":"1993","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tice.2014.08.001_bib0120","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrurol.2011.112","article-title":"Urological aspects of the metabolic syndrome","volume":"8","author":"Hammarsten","year":"2011","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0033-8389(05)70146-9","article-title":"The prostate: development and physiology","volume":"38","author":"Hayward","year":"2000","journal-title":"Radiol. Clin. North Am."},{"key":"10.1016\/j.tice.2014.08.001_bib0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1464-410X.1997.tb16917.x","article-title":"Stromal\u2013epithelial interactions in the normal and neoplastic prostate","volume":"79","author":"Hayward","year":"1997","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0135","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00345-005-0019-1","article-title":"Nitric oxide\/cGMP-mediated effects in the out-flow region of the lower urinary tract \u2013 is there a basis for pharmacological targeting of cGMP?","volume":"23","author":"Hedlund","year":"2005","journal-title":"World J. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0140","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0022-5347(05)67812-3","article-title":"Is low serum free testosterone a marker for high grade prostate cancer?","volume":"163","author":"Hoffman","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0145","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00345-008-0303-y","article-title":"The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms","volume":"26","author":"Kedia","year":"2008","journal-title":"World J. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","article-title":"Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics","volume":"26","author":"Kerr","year":"1972","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tice.2014.08.001_bib0155","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1006\/bbrc.1993.1506","article-title":"Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-\u03b2 and a proteolytic modulation of cell adhesion receptors","volume":"192","author":"Killian","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tice.2014.08.001_bib0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1172\/JCI113070","article-title":"Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen","volume":"80","author":"Lilja","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tice.2014.08.001_bib0165","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/pros.20634","article-title":"cGMP-enhancing- and \u03b11A\/\u03b11D-adrenoceptor blockade-derived inhibition of Rho-kinase by KMUP-1 provides optimal prostate relaxation and epithelial cell anti-proliferation efficacy","volume":"67","author":"Liu","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.tice.2014.08.001_bib0170","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.juro.2006.10.055","article-title":"Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial","volume":"177","author":"McVary","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0175","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1464-410X.2006.06102.x","article-title":"Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology","volume":"97","author":"McVary","year":"2006","journal-title":"BJU Int."},{"key":"10.1016\/j.tice.2014.08.001_bib0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1095\/biolreprod51.1.99","article-title":"Growth of the rat prostate gland is facilitated by the autonomic nervous system","volume":"51","author":"McVary","year":"1994","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.tice.2014.08.001_bib0185","first-page":"589","article-title":"Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia","volume":"8","author":"Moon","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tice.2014.08.001_bib0190","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1743-6109.2006.00259.x","article-title":"Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction","volume":"3","author":"Mulhall","year":"2006","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.tice.2014.08.001_bib0195","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI35079","article-title":"Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer","volume":"119","author":"Nanni","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tice.2014.08.001_bib0200","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/pros.21157","article-title":"Androgens regulate adenylate cyclase activity and intracellular calcium in stromal cells derived from human prostate","volume":"70","author":"Oliver","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.tice.2014.08.001_bib0205","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.eururo.2006.05.040","article-title":"The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia","volume":"51","author":"Ozden","year":"2007","journal-title":"Eur. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0210","first-page":"3961","article-title":"Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis","volume":"61","author":"Piazza","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.tice.2014.08.001_bib0215","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/ijc.24084","article-title":"Nitric oxide stimulates migration of human endothelial and prostate cancer cells through up-regulation of pleiotrophin expression and its receptor protein tyrosine phosphatase beta\/zeta","volume":"124","author":"Polytarchou","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tice.2014.08.001_bib0220","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.juro.2008.06.079","article-title":"Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study","volume":"180","author":"Roehrborn","year":"2008","journal-title":"J. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0225","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.urolonc.2009.04.011","article-title":"Despite the lack of association between different genotypes and the presence of prostate cancer, endothelial nitric oxide synthase a\/b (eNOS4a\/b) polymorphism may be associated with advanced clinical stage and bone metastasis","volume":"29","author":"Sanli","year":"2011","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.tice.2014.08.001_bib0230","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2613.2009.00660.x","article-title":"Chronic treatment with sildenafil stimulates Leydig cell and testosterone secretion","volume":"90","author":"Saraiva","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.tice.2014.08.001_bib0235","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2002-01-0075","article-title":"Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells","volume":"101","author":"Sarfati","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.tice.2014.08.001_bib0240","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1200\/JCO.2001.19.5.1304","article-title":"Serum prostate-specific antigen decline as a marker of clinical outcome in hormone-refractory prostate cancer patients: association with progression-free survival, pain end points, and survival","volume":"19","author":"Small","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tice.2014.08.001_bib0245","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.eururo.2008.01.075","article-title":"A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"53","author":"Stief","year":"2008","journal-title":"Eur. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0250","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/jnci\/91.19.1663","article-title":"Growth regulation of prostatic stromal cells by prostate-specific antigen","volume":"91","author":"Sutkowski","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"issue":"8","key":"10.1016\/j.tice.2014.08.001_bib0255","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1242\/dev.129.8.1905","article-title":"The role of smooth muscle in regulating prostatic induction","volume":"129","author":"Thomson","year":"2002","journal-title":"Development"},{"key":"10.1016\/j.tice.2014.08.001_bib0265","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.eururo.2006.05.025","article-title":"Update on phosphodiesterase (PDE) isoenzymes as pharmacological targets in urology: present and future","volume":"50","author":"\u00dcckert","year":"2006","journal-title":"Eur. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0270","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eururo.2005.12.050","article-title":"Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate","volume":"49","author":"\u00dcckert","year":"2006","journal-title":"Eur. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0275","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s002400000148","article-title":"Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 inhuman prostate cancer","volume":"29","author":"Uotila","year":"2001","journal-title":"Urol. Res."},{"key":"10.1016\/j.tice.2014.08.001_bib0280","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.cca.2012.06.007","article-title":"Glycosylation of prostate specific antigen and its potential diagnostic applications","volume":"413","author":"Vermassen","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.tice.2014.08.001_bib0285","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/pros.22686","article-title":"PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS","volume":"73","author":"Vignozzi","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.tice.2014.08.001_bib0290","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.eururo.2007.02.004","article-title":"Immunohistochemical distribution of cyclic GMP-dependent protein kinase-1 in human prostate tissue","volume":"52","author":"Waldkirch","year":"2007","journal-title":"Eur. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0295","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MOU.0b013e328333ac68","article-title":"Phosphodiesterase-5 inhibitors and benign prostatic hyperplasia","volume":"20","author":"Wang","year":"2010","journal-title":"Curr. Opin. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0300","first-page":"1089","article-title":"Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion","volume":"1","author":"Webber","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tice.2014.08.001_bib0305","first-page":"479","article-title":"Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival","volume":"2","author":"Whitehead","year":"2003","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tice.2014.08.001_bib0310","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MOU.0b013e328316c357","article-title":"Phosphodiesterase 5 inhibitors in the management of benign prostatic hyperplasia and erectile dysfunction: the best of both worlds","volume":"19","author":"Wong","year":"2009","journal-title":"Curr. Opin. Urol."},{"key":"10.1016\/j.tice.2014.08.001_bib0315","first-page":"681","article-title":"The positive effect of sildenafil on LUTS from BPH while treating ED","volume":"10","author":"Ying","year":"2004","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1016\/j.tice.2014.08.001_bib0320","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1158\/0008-5472.CAN-06-2149","article-title":"An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer","volume":"67","author":"Ying","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.tice.2014.08.001_bib0325","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canlet.2012.09.006","article-title":"Increased expression of activated endothelial nitric oxide synthase contributes to antiandrogen resistance in prostate cancer cells by suppressing androgen receptor transactivation","volume":"328","author":"Yu","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tice.2014.08.001_bib0330","series-title":"Biostatistical Analysis","author":"Zar","year":"1996"},{"key":"10.1016\/j.tice.2014.08.001_bib0335","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/01.CIR.0000050653.10758.6B","article-title":"Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic peptide activity","volume":"107","author":"Zhao","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.tice.2014.08.001_bib0340","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/hc2901.093117","article-title":"Sildenafil inhibits hypoxia pulmonary hypertension","volume":"104","author":"Zhao","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.tice.2014.08.001_bib0350","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5301\/JBM.2012.9585","article-title":"Endothelial nitric oxide synthase Glu298Asp polymorphism as a risk factor for prostate cancer","volume":"28","author":"Ziaei","year":"2013","journal-title":"Int. J. Biol. Markers"}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816614000706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816614000706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:13:16Z","timestamp":1758571996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816614000706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0040816614000706"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2014.08.001","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of chronic Sildenafil treatment on the prostate of C57Bl\/6 mice","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2014.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}